Luzu (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Luzu drug offered from Valeant Pharmaceuticals North America LLC. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
| NON-PROPRIETARY NAME: | LULICONAZOLE |
| SUBSTANCE NAME: | LULICONAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 2C19 Inhibitors [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-11-14 |
| END MARKETING DATE: | 0000-00-00 |
Luzu HUMAN PRESCRIPTION DRUG Details:
| Item Description | Luzu from Valeant Pharmaceuticals North America LLC |
| LABELER NAME: | Valeant Pharmaceuticals North America LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/g) |
| START MARKETING DATE: | 2013-11-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 99207-850_4fa7e444-9f5d-4174-b9d6-853fa6b0d860 |
| PRODUCT NDC: | 99207-850 |
| APPLICATION NUMBER: | NDA204153 |
Other LULICONAZOLE Pharmaceutical Manufacturers / Labelers:
